Checked against public sources on August 1, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
Every ingredient shows its amount · 3 ingredients listed. Every ingredient shows its real amount — nothing is hidden in a proprietary blend.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| NMN (β-Nicotinamide Mononucleotide) | 500 mg |
|---|---|
| Trans-Resveratrol (from Japanese Knotweed Extract (Polygonum cuspidatum, Root)) | 400 mg |
| Black Pepper Extract (Piper nigrum, Fruit) | 50 mg |
Printed on the package: Gluten Free · Wheat Free · 3RD PARTY QUALITY TESTED · VEGAN FRIENDLY · MADE IN USA
We read 3 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
1 promise needs a closer look.
Published research exists for ingredients in this formula. Whether this product’s doses match those studies could not be confirmed.
Ingredient research can support context, but it is not a trial of this exact product.
We found no study of this product measuring the stated outcome over the stated timeframe.
“Made in USA” can describe only final bottling. Ingredient-sourcing records were not located for this product.
We looked and found no public proof. That does not count against the product.
Headlines first. Open evidence only when you want the source trail.
Every ingredient shows its real amount — nothing is hidden in a proprietary blend.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
Filed address
1226 N KING ST NUM 226, WILMINGTON, Delaware 19801, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 500 mg of NMN (nicotinamide mononucleotide) per serving. Studies we found used 250 mg–1 g a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.
Lowest New observed via Keepa on 2026-08-01.
View on Amazon ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search iHerb ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Target ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Walmart ↗Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.
The summary stops at product-specific facts. The full report preserves every source, calculation, limitation, and unresolved check for review or sharing.
Record built August 02, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.